搜索
Apogee Therapeutics Inc
APGE添加自选
135.070USD
-0.010-0.01%
收盘 09-02 16:00（美东）
10.18B总市值
亏损市盈率 TTM
股东统计
更新时间: 5月12日 周二
更新时间: 5月12日 周二
持股股东
股东类型
持股股东
持股股东
占比
T. Rowe Price Investment Management, Inc.
16.62%
VR Adviser, LLC
13.72%
Fidelity Management & Research Company LLC
13.17%
Wellington Management Company, LLP
7.67%
BlackRock Institutional Trust Company, N.A.
4.86%
其他
43.96%
持股股东
持股股东
占比
T. Rowe Price Investment Management, Inc.
16.62%
VR Adviser, LLC
13.72%
Fidelity Management & Research Company LLC
13.17%
Wellington Management Company, LLP
7.67%
BlackRock Institutional Trust Company, N.A.
4.86%
其他
43.96%
股东类型
持股股东
占比
Investment Advisor
56.14%
Investment Advisor/Hedge Fund
36.88%
Venture Capital
15.55%
Hedge Fund
10.52%
Individual Investor
6.18%
Private Equity
3.77%
Research Firm
3.56%
Corporation
3.54%
Bank and Trust
0.35%
机构持股
更新时间: 4月1日 周三
更新时间: 4月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q1
448
78.72M
127.37%
+2.92M
2025Q4
397
62.08M
122.90%
+514.48K
2025Q3
401
61.56M
114.17%
+657.36K
2025Q2
380
59.46M
152.78%
-3.62M
2025Q1
350
63.05M
144.49%
-1.71M
2024Q4
317
59.56M
136.18%
+2.59M
2024Q3
286
56.94M
102.46%
+1.98M
2024Q2
257
54.87M
111.46%
+7.98M
2024Q1
220
46.85M
77.95%
+13.42M
2023Q4
148
35.59M
92.12%
+1.64M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
T. Rowe Price Investment Management, Inc.
6.21M
10.26%
+3.48M
+127.41%
Feb 28, 2026
VR Adviser, LLC
8.49M
14.03%
--
--
Dec 31, 2025
Fidelity Management & Research Company LLC
8.15M
13.46%
+1.27M
+18.50%
Dec 31, 2025
Wellington Management Company, LLP
4.75M
7.84%
+22.88K
+0.48%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
3.01M
4.97%
+570.98K
+23.42%
Dec 31, 2025
RTW Investments L.P.
2.71M
4.48%
--
--
Dec 31, 2025
Perceptive Advisors LLC
2.33M
3.85%
+978.66K
+72.39%
Dec 31, 2025
Access Industries, Inc.
2.19M
3.62%
+250.00K
+12.88%
Sep 30, 2024
Driehaus Capital Management, LLC
2.18M
3.61%
+25.20K
+1.17%
Dec 31, 2025
查看更多
ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Goldman Sachs Future Health Care Equity ETF
1.11%
ALPS Medical Breakthroughs ETF
1.1%
JPMorgan Healthcare Leaders ETF
1.05%
Virtus LifeSci Biotech Clinical Trials ETF
0.92%
State Street SPDR S&P Biotech ETF
0.91%
First Trust Multi-Manager Small Cap Opportunities ETF
0.81%
Direxion Daily S&P Biotech Bull 3X Shares
0.56%
JPMorgan Fundamental Data Science Small Core ETF
0.44%
ProShares Ultra Nasdaq Biotechnology
0.4%
Invesco Nasdaq Biotechnology ETF
0.25%
查看更多
Goldman Sachs Future Health Care Equity ETF
占比1.11%
ALPS Medical Breakthroughs ETF
占比1.1%
JPMorgan Healthcare Leaders ETF
占比1.05%
Virtus LifeSci Biotech Clinical Trials ETF
占比0.92%
State Street SPDR S&P Biotech ETF
占比0.91%
First Trust Multi-Manager Small Cap Opportunities ETF
占比0.81%
Direxion Daily S&P Biotech Bull 3X Shares
占比0.56%
JPMorgan Fundamental Data Science Small Core ETF
占比0.44%
ProShares Ultra Nasdaq Biotechnology
占比0.4%
Invesco Nasdaq Biotechnology ETF
占比0.25%